News
Update: Value-Based Pricing in the UK
11 January 2011
Value-based pricing for new medicines, proposed as part of UK health care reform, would create a QALY-plus approach for drugs approved starting 1 January 2014. For…
Measuring Value: OHE at ISPOR
4 January 2011
Members of the OHE team participated in a number of sessions at ISPOR’s 13th Annual European Congress in November. This post summarizes the contributions of Prof…
Seminar Briefing on Science Policy
23 December 2010
At a recent OHE seminar, Prof Ben Martin (Science and Technology Policy Studies at SPRU, University of Sussex) presented the results of his extensive literature review…
Report on Orphan Drugs Released
9 December 2010
OHE Consulting has released new research on orphan medicinal products (OMPs) in Europe that assesses the effects of the European Union’s 1999 Regulation on Orphan Medicinal…
Australia’s Publicly Funded Vaccines Market
1 December 2010
The OHE recently published reports on the vaccines markets in Australia and in the UK, originally prepared as case studies for a project funded by the…
Prof Devlin Elected Chair of EuroQol Group
25 November 2010
OHE is pleased to announce that Professor Nancy Devlin, Director of Research, has been elected as Chair of the EuroQol Group’s executive committee, effective as from…
The UK’s Publicly Funded Vaccines Market
23 November 2010
The OHE has just published reports on the vaccines markets in Australia and in the UK, originally prepared as case studies for a project funded by…
Annual Lecture Publication Now Available
16 November 2010
Now available is the full text of Dr Alan Garber’s remarks at the OHE Annual Lecture. Each year, the OHE sponsors a lecture that explores a…
Disease severity and public preferences
4 November 2010
Does including the name of a specific severe disease in preference surveys affect public attitudes toward resource allocation? A recent proof of concept study suggests that…